Gangliosidoses, GM2

Overview

A group of recessively inherited diseases characterized by the intralysosomal accumulation of G(M2) GANGLIOSIDE in the neuronal cells. Subtypes include mutations of enzymes in the BETA-N-ACETYLHEXOSAMINIDASES system or G(M2) ACTIVATOR PROTEIN leading to disruption of normal degradation of GANGLIOSIDES, a subclass of ACIDIC GLYCOSPHINGOLIPIDS.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Gangliosidoses, GM2

Topic type

Condition

Category

Neurology

MeSH classification

C10.228.140.163.100.435.825.300.300|C16.320.565.189.435.825.300.300|C16.320.565.398.641.803.350.300|C16.320.565.595.554.825.300.300|C18.452.132.100.435.825.300.300|C18.452.584.563.641.803.350.300|C18.452.648.189.435.825.300.300|C18.452.648.398.641.803.350.300|C18.452.648.595.554.825.300.300

Preparing for an appointment about Gangliosidoses, GM2

If you are speaking with a healthcare professional about Gangliosidoses, GM2, it can help to prepare a few details in advance.

• Write down your symptoms and when they started.
• Bring details of any medicines, supplements or previous treatments.
• Ask what tests or assessments may be needed.
• Ask what treatment or management options may be suitable.
• Ask when you should seek urgent medical help or follow-up care.

Finding care related to Gangliosidoses, GM2

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.